Priapism and phimosis in sickle cell anemia
Keywords:
priapismo, phimosis, anemia drepanocítica, erectile dysfunctionAbstract
Priapismo is the abnormal, prolonged and painful erection of the penis, not related with sexual desire. An emergency is urological, and the premature intervention offers the best opportunity for the functional recuperation. Hygiene and the preputial adequate care are fundamental to avoid the fibrosis of the ring prepucial and the development of phimosis. An adolescent afflicted of both affections with consequence of erectile irreversible dysfunction after surgical treatment shows up. The priapismo in the Anemia Drepanocítica is of low flow; It must be diagnosed and processed rapidly. The therapeutic initial boarding must be individualized; You are recommended in the first 12 hours aspiration and direct irrigation of the cavernous bodies with agents diluted simpaticomiméticos and, in case of failing the aforementioned procedures, making the surgical anastomosis of the cavernous bodies toward the spongy body or venous affluents.Downloads
References
1. Castro Maldonado O, Meléndez Borges JE, Pedro Silva IE, Mirabal Fariñas A, Rodríguez Morales A. Caracterización epidemiológica, diagnóstica y terapéutica de pacientes con priapismo. Medisan [Internet]. 2015 [citado 31 Oct 2019]; 19(10):[aprox. 10p.]. Disponible en: http://medisan.sld.cu/index.php/san/article/view/474/pdf_155
2. Broseta Rico E, Judia A, Burgues JP, Luján S, Jiménez Cruz JF. Urgencias en Urología. Priapismo. En: Urología Práctica. 3a ed. España: Editorial Ene Ediciones; 2011. p. 36-8.
3. Anel UA, Le BV, Resar LMS, Burnett AL. How I treat priapism. Blood [Internet]. 2015 [citado 31 Oct 2019]; 125(23):[aprox. 7p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458797/
4. Levey HL, Segal RL, Bivalacqua TJ. Management of priapism: an update for clinicians Ther Adv Urol [Internet]. 2014 [citado 31 Oct 2019]; 6(6): [aprox. 14p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236300/
5. Anele UA, Morrison BF, Burnett AL. Molecular Pathophysiology of Priapism: emerging targets. Curr Drug Targets [Internet]. 2015 [citado 31 Oct 2019]; 16(5):[aprox. 9p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25392014
6. Cita KC, Brureau L, Lemonne N, Billaud M, Connes P, Ferdinand S, et al. Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength. PLoS One [Internet]. 2016 [citado 31 Oct 2019]; 11(5): [aprox. 9p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856257/pdf/pone.0154866.pdf
7. Jesus LE, Teixeira L, Bertelli A. Recurring priapism may be a symptom of voiding dysfunction - case report and literature review. Int Braz J Urol [Internet]. 2016 [citado 31 Oct 2019]; 42(2): [aprox. 2p.]. Disponible en: http://www.scielo.br/pdf/ibju/v42n2/1677-5538-ibju-42-02-0389.pdf
8. Cox G, Krieger JN, Morris BJ. Histological Correlates of Penile Sexual Sensation: Does Circumcision Make a Difference? Sex Med [Internet]. 2015 [citado 31 Oct 2019]; 3(2):[aprox. 9p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498824/pdf/sm20003-0076.pdf
9. Shahid SK. Phimosis in Children. ISRN Urol [Internet]. 2012 [citado 31 Oct 2019]; 2012:[aprox. 5p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329654/pdf/ISRN.UROLOGY2012-707329.pdf
10. Parra Tello T, Hernández Ramos MI, Pérez Tapia SM, Limón Flores AY. Estudio retrospectivo del efecto del furoato de mometasona al 0.1% en el tratamiento no quirúrgico de fimosis y adherencias prepuciales en niños mexicanos. Bol. Med. Hosp. Infant. Mex [Internet]. 2012 [citado 31 Oct 2019]; 69(1): [aprox. 5p.]. Disponible en: http://www.scielo.org.mx/pdf/bmim/v69n1/v69n1a4.pdf
11. Lee CH, Lee SD. Effect of Topical Steroid (0.05% Clobetasol Propionate) Treatment in Children with Severe Phimosis. Korean J Urol [Internet]. 2013 [citado 31 Oct 2019]; 54(9):[aprox. 6p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773594/pdf/kju-54-624.pdf

Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).